+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Balloon Catheters Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • April 2024
  • Region: Global
  • Expert Market Research
  • ID: 5960361
The global balloon catheters market size was valued at USD 4.5 billion in 2023. It is expected to grow at a CAGR of 6.50% during the forecast period of 2024-2032, driven by technological advancements and rising preference for minimally invasive procedures. The market is experiencing robust growth and is expected to reach USD 8.1 billion by 2032.

Global Balloon Catheters Market Analysis

The global balloon catheters market is experiencing substantial growth, driven by advancements in cardiovascular treatments, the increasing prevalence of coronary artery diseases, and the rising demand for minimally invasive surgeries. This market analysis explores the key factors contributing to the growth, challenges faced, and future prospects of the balloon catheters industry.

Market Drivers

One of the primary drivers of the balloon catheters market is the significant rise in cardiovascular diseases globally, including coronary artery disease, peripheral artery disease, and renal artery disease. The aging population and lifestyle-related risk factors such as hypertension, diabetes, and obesity contribute to this increase. Furthermore, technological advancements in balloon catheters, including the development of drug-eluting, cutting, and scoring balloon catheters, offer more effective and patient-friendly treatment options. The growing preference for minimally invasive procedures, which reduce hospital stays and recovery times, also fuels market growth.

Market Challenges

Despite the growth, the market faces challenges such as stringent regulatory approvals, which can delay product launches, and the risk of complications associated with balloon catheterization procedures, such as artery dissection and restenosis. Additionally, the high cost of advanced balloon catheters and the lack of reimbursement policies in certain regions may limit market accessibility and affordability for patients.

Global Balloon Catheters Market Outlook

The balloon catheters market is poised for continued expansion, with innovation and global health trends shaping its trajectory. The development of more sophisticated balloon catheter technologies that offer safer and more effective treatment options is anticipated. Additionally, expanding healthcare infrastructure and access in emerging markets presents significant growth opportunities for the industry.

Global Balloon Catheters Market Trends

The global balloon catheters market is marked by several dynamic trends that reflect the evolving landscape of cardiovascular and peripheral treatments. These trends underscore the market's response to technological advancements, changing healthcare needs, and the growing emphasis on minimally invasive procedures. Below are key trends shaping the global balloon catheters market:
  • Technological Innovation and Product Diversification
The market is witnessing rapid technological advancements, with manufacturers focusing on developing innovative balloon catheters that offer improved outcomes and greater ease of use. Innovations include drug-eluting balloon catheters that deliver medication directly to the site of the lesion, cutting and scoring balloons designed to tackle calcified lesions, and balloons made with novel materials for better flexibility and durability. This trend towards innovation and diversification is aimed at addressing the wide range of clinical needs and complications encountered in interventional procedures.
  • Increasing Demand for Minimally Invasive Procedures
There is a growing preference for minimally invasive surgeries across the healthcare sector, driven by the benefits of shorter recovery times, reduced procedural risks, and lower costs. Balloon catheters play a crucial role in such procedures, especially in the treatment of cardiovascular diseases, peripheral artery diseases, and neurovascular interventions. This trend is expected to continue, fueling the demand for balloon catheters.
  • Rising Prevalence of Cardiovascular Diseases
The increasing incidence of cardiovascular diseases (CVDs) globally, due to factors such as aging populations, lifestyle changes, and the rising prevalence of diabetes and obesity, is a major driver for the balloon catheters market. The need for effective and efficient treatment options for CVDs is pushing the adoption of advanced balloon catheter technologies.
  • Expansion in Emerging Markets
Emerging economies present significant growth opportunities for the balloon catheters market, thanks to improving healthcare infrastructure, increasing healthcare spending, and a growing awareness of treatment options. Countries in the Asia Pacific region, Latin America, and parts of Africa are witnessing rapid economic growth, which is expected to increase access to healthcare services and, consequently, the demand for balloon catheter-based treatments.
  • Regulatory and Reimbursement Challenges
The market's growth is also influenced by the regulatory landscape, which varies across regions and can impact the approval and adoption of new balloon catheter technologies. Additionally, reimbursement policies affect the affordability and accessibility of advanced treatments for patients, posing a challenge for market expansion.

In summary, the global balloon catheters market is experiencing significant growth and transformation, driven by technological innovation, the rising demand for minimally invasive procedures, and the increasing prevalence of cardiovascular diseases. These trends, coupled with market expansion in emerging economies and strategic industry movements, are shaping the future of the balloon catheters market.

Global Balloon Catheters Market Segmentation

Market Breakup by Product

  • Rapid Exchange (RX) Balloon Catheters
  • Over-The-Wire (OTW) Balloon Catheters
  • Drug Eluting Balloon Catheters
  • Stent Graft Balloon Catheters
  • Others
The global balloon catheters market is segmented by product into Rapid Exchange (RX) Balloon Catheters, Over-The-Wire (OTW) Balloon Catheters, Drug Eluting Balloon Catheters, Stent Graft Balloon Catheters, and others. RX and OTW balloon catheters, known for their ease of use and precision, cater to a wide range of interventional procedures, driving their demand. Drug Eluting Balloon Catheters are gaining traction for their ability to deliver medication directly to the lesion site, offering a significant growth avenue due to their role in reducing restenosis rates.

Stent graft balloon catheters are essential in treating aortic aneurysms and peripheral vascular diseases, with their demand poised to rise alongside the prevalence of these conditions. The "others" category, encompassing specialty balloons for niche applications, further diversifies the market's growth prospects. Collectively, these segments, propelled by technological advancements and the increasing demand for minimally invasive procedures, are set to drive the market's expansion in the forecast period.

Market Breakup by Indication

  • Coronary Artery Disease
  • Peripheral Vascular Disease
The global balloon catheters market, segmented by indication into coronary artery disease (CAD) and peripheral vascular disease (PVD), showcases distinct growth drivers and future potential. CAD, as a leading cause of morbidity and mortality worldwide, drives a significant demand for balloon catheters in angioplasty procedures, stent placements, and other coronary interventions. The rising prevalence of CAD, fueled by aging populations, lifestyle factors, and the global increase in cardiovascular risk factors, positions this segment for sustained growth.

On the other hand, PVD, encompassing a range of conditions affecting non-coronary arteries, is witnessing an uptick in treatment demand due to improved diagnostic techniques and a growing awareness of the disease. The expansion in treatment modalities for PVD, including the use of balloon catheters for limb salvage and reducing the risk of amputation, further underscores the segment's potential for growth. Both segments are pivotal in driving the overall market expansion, with innovations in balloon catheter technology and a focus on minimally invasive techniques poised to meet the increasing demand across these indications.

Market Breakup by End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
The global balloon catheters market, when segmented by end-user, encompasses hospitals, ambulatory surgical centers (ASCs), and others. Hospitals, being the primary setting for a wide range of invasive procedures, including those for coronary and peripheral vascular diseases, hold the largest share. This dominance is attributed to their comprehensive facilities, availability of specialized personnel, and capacity to handle complex cases. Ambulatory Surgical Centers are experiencing rapid growth, driven by the shift towards minimally invasive surgeries that favor quick recovery and lower costs, making ASCs an increasingly preferred choice for balloon catheterization procedures.

The "others" category, which includes clinics and outpatient care centers, caters to less invasive procedures and follow-up care, playing a crucial role in the continuum of care. These end-user segments highlight the market's adaptability to different healthcare settings, with hospitals leading in volume and ASCs in growth potential, reflecting broader trends towards efficiency and patient-centric care in healthcare delivery.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global balloon catheters market is segmented regionally into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and significant investments in research and development. Europe follows closely, with its strong healthcare systems, regulatory support for medical devices, and increasing demand for minimally invasive procedures. The Asia Pacific region is identified as the fastest-growing market due to its expanding healthcare sector, rising middle-class population, and increasing awareness of cardiovascular health.

Latin America and the Middle East and Africa are emerging markets with growth potential, bolstered by improving healthcare facilities and growing healthcare expenditures. Each region's market dynamics are influenced by local healthcare policies, economic conditions, and technological adoption rates, collectively contributing to the global expansion of the balloon catheters market.

Global Balloon Catheters Market Competitive Landscape

The global balloon catheters market features a competitive landscape with key players such as Medtronic, Boston Scientific Corporation, Abbott, Spectrum Plastics Group, Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc., B. Braun SE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology, and INVAMED among others.

The companies contribute to the market's diversity with unique and targeted balloon catheter technologies, making the landscape highly dynamic and competitive.

Key Questions Answered in the Report

  • What is the current and future performance of the global balloon catheters market?
  • What are the key drivers and challenges in the balloon catheters market?
  • What are the key trends shaping the global balloon catheters market?
  • What is driving the adoption of advanced balloon catheter technologies in the global market?
  • How is the increasing demand for minimally invasive procedures impacting the balloon catheters market?
  • How is the global balloon catheters market segmented by indication, and what drives its growth?
  • Who are the key players in the global balloon catheters market, and how do they contribute to its competitiveness?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global balloon catheters market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global balloon catheters market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global balloon catheters industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Balloon Catheters Market Overview
3.1 Global Balloon Catheters Market Historical Value (2017-2023)
3.2 Global Balloon Catheters Market Forecast Value (2024-2032)
4 Global Balloon Catheters Market Landscape*
4.1 Global Balloon Catheters Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Balloon Catheters Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Indication
4.2.3 Analysis by Raw Material
5 Global Balloon Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Balloon Catheters Market Segmentation (2017-2032)
6.1 Global Balloon Catheters Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Rapid Exchange (RX) Balloon Catheters
6.1.3 Over-The-Wire (OTW) Balloon Catheters
6.1.4 Drug Eluting Balloon Catheters
6.1.5 Stent Graft Balloon Catheters
6.1.6 Others
6.2 Global Balloon Catheters Market (2017-2032) by Indication
6.2.1 Market Overview
6.2.2 Coronary Artery Disease
6.2.3 Peripheral Vascular Disease
6.3 Global Balloon Catheters Market (2017-2032) by End-user
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Others
6.4 Global Balloon Catheters Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Balloon Catheters Market (2017-2032)
7.1 North America Balloon Catheters Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Rapid Exchange (RX) Balloon Catheters
7.1.3 Over-The-Wire (OTW) Balloon Catheters
7.1.4 Drug Eluting Balloon Catheters
7.1.5 Stent Graft Balloon Catheters
7.1.6 Others
7.2 North America Balloon Catheters Market (2017-2032) by Indication
7.2.1 Coronary Artery Disease
7.2.2 Peripheral Vascular Disease
7.3 North America Balloon Catheters Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Balloon Catheters Market (2017-2032)
8.1 Europe Balloon Catheters Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Rapid Exchange (RX) Balloon Catheters
8.1.3 Over-The-Wire (OTW) Balloon Catheters
8.1.4 Drug Eluting Balloon Catheters
8.1.5 Stent Graft Balloon Catheters
8.1.6 Others
8.2 Europe Balloon Catheters Market (2017-2032) by Indication
8.2.1 Coronary Artery Disease
8.2.2 Peripheral Vascular Disease
8.3 Europe Balloon Catheters Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Balloon Catheters Market (2017-2032)
9.1 Asia Pacific Balloon Catheters Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Rapid Exchange (RX) Balloon Catheters
9.1.3 Over-The-Wire (OTW) Balloon Catheters
9.1.4 Drug Eluting Balloon Catheters
9.1.5 Stent Graft Balloon Catheters
9.1.6 Others
9.2 Asia Pacific Balloon Catheters Market (2017-2032) by Indication
9.2.1 Coronary Artery Disease
9.2.2 Peripheral Vascular Disease
9.3 Asia Pacific Balloon Catheters Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Balloon Catheters Market (2017-2032)
10.1 Latin America Balloon Catheters Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Rapid Exchange (RX) Balloon Catheters
10.1.3 Over-The-Wire (OTW) Balloon Catheters
10.1.4 Drug Eluting Balloon Catheters
10.1.5 Stent Graft Balloon Catheters
10.1.6 Others
10.2 Latin America Balloon Catheters Market (2017-2032) by Indication
10.2.1 Coronary Artery Disease
10.2.2 Peripheral Vascular Disease
10.3 Latin America Balloon Catheters Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Balloon Catheters Market (2017-2032)
11.1 Middle East and Africa Balloon Catheters Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Rapid Exchange (RX) Balloon Catheters
11.1.3 Over-The-Wire (OTW) Balloon Catheters
11.1.4 Drug Eluting Balloon Catheters
11.1.5 Stent Graft Balloon Catheters
11.1.6 Others
11.2 Middle East and Africa Balloon Catheters Market (2017-2032) by Indication
11.2.1 Coronary Artery Disease
11.2.2 Peripheral Vascular Disease
11.3 Middle East and Africa Balloon Catheters Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Spectrum Plastics Group
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Biotronik
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shanghai MicroPort Medical (Group) Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Artivion, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 B. Braun SE
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cook Group Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Becton, Dickinson and Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Cardinal Health
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Terumo Medical Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Coloplast Group
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Lepu Medical Technology (Beijing)Co.,Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 INVAMED
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Balloon Catheters Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Spectrum Plastics Group
  • Biotronik
  • Shanghai MicroPort Medical (Group) Co. Ltd.
  • Artivion Inc
  • B. Braun SE
  • Cook Group Incorporated
  • Becton, Dickinson and Company
  • Cardinal Health
  • Terumo Medical Corporation
  • Coloplast Group
  • Lepu Medical Technology (Beijing)Co.Ltd.
  • INVAMED

Methodology

Loading
LOADING...